Navigation Links
To Avert Daunting Losses, Drug Companies Must Better Manage Patent Expirations of Established Products

CHAPEL HILL, N.C., June 21, 2013 /PRNewswire/ -- With all brand drugs inevitably facing patent loss, pharmaceutical companies are increasingly focused on enhancing their lifecycle management (LCM). In order to fully take advantage of each brand at every stage of its life, including the often neglected back end, brand management leaders have been actively investigating the best practices associated with extending and maximizing the life of a mature product.

To meet the growing needs of brand leaders, research and consulting firm Best Practices, LLC has published, "Lifecycle Management Excellence: High-Performing Strategies Used to Maximize Potential of Mature Brands". The report examines the effectiveness of more than 20 strategies for prolonging the commercial life of mature pharmaceutical products. The study found the average financial gain from using individual lifecycle management strategies for a mature brand was $254 million – illustrating the value of understanding how to successfully manage a lifecycle management program for a mature product.

The benchmarking report also addresses key issues that are integral to lifecycle management, such as:

  • Success rates & ROI of different strategies that leading companies have used to maximize mature-brand value.
  • Relative cost, time, complexity, & regulatory barriers encountered with using each strategy.
  • An overview of the operation, expenses, responsibilities & business impact of dedicated mature brand (MB) groups.

The 76-page report delivers hard-to-find benchmarks that will allow executives to better examine industry standards for implementation time, cost and ROI of frequently used lifecycle management strategies. It also provides critical benchmarks on the optimal size and structure of Mature Brand Organizations, as well as the barriers and regulations affecting the strategies used by Mature Brand Organizations.

Participants for the research included 25 executives and managers from 18 different pharmaceutical and biotech companies. Respondents represented 12 different therapeutic areas.

To access the full report, or to download a complimentary summary containing insights found in this report, click on the following link:

For more information on this study or other recent primary research studies, contact us at 919.403.0251 or to learn more about best practices in brand management and other benchmarking insights, visit our website at


Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.




SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Tektronix Donates Oscilloscope to Beaverton High School
2. Par Pharmaceutical Companies Reports First Quarter 2012 Results
3. New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
4. UBM Canon, the Global MedTech Authority, Partners with the World Medical Device Organization, WMDO, to Provide Medical Device Companies with Industry-Related Online Training Solutions
5. Par Pharmaceutical Companies to Report Second Quarter 2012 Results on August 2, 2012
6. Life Sciences Companies Webcast Live to Online Investors, July 12th, at
7. Info Graphic: Middle managers are frozen by information overload, costing companies millions
8. Par Pharmaceutical Companies, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By TPG
9. Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities
10. Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Par Pharmaceutical Companies, Inc.
11. PAREXEL Launches The PAREXEL BioPharm Unit To Meet The Critical Development Goals Of Small And Mid-Sized Biopharmaceutical Companies
Post Your Comments:
(Date:11/27/2015)... 2015 Research and Markets ( ) ... Devices Market 2015-2019" report to their offering. ... this report, the author the present scenario and growth ... To calculate the market size, the report considers revenue ... Hormonal IUDs and copper IUDs. The report forecasts the ...
(Date:11/26/2015)... November 27, 2015 ... --> Medical alert ... system (PERS) market is expected ... years with APAC being the ... see a high CAGR between ...
(Date:11/26/2015)... North Carolina , 26 november 2015 ... Inc. (AAIPharma/CML) kondigt de geplande investering aan ... uitbreiding van de laboratoria en het mondiale ... . De uitbreiding zal resulteren in extra ... wordt voldaan aan de groeiende behoeften van ...
Breaking Medicine Technology:
(Date:11/27/2015)... Chicago, IL (PRWEB) , ... November 27, 2015 ... ... some of the largest, most successful and prominent nonprofit healthcare organizations in the ... and governance involvement with various organizations, and helped advance the healthcare industry as ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... Avid collector, ... Ann Arbor Michigan boxing style concert posters. This is one of Joplin's most famous ... Canterbury House at the University of Michigan in Ann Arbor. The According to Hawley, ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... located in central Michigan, have come together on Thanksgiving Day to share the ... available for viewing on the Serenity Point YouTube channel, patients displayed what they ...
(Date:11/26/2015)... ... November 26, 2015 , ... CognisantMD ... for diagnostic imaging in the Waterloo region. Using the Ocean Platform, family physicians ... directly from their electronic medical record (EMR) without the need for redundant patient ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent Applied Drug ... need to integrate dose form selection in early phase drug development. The first ... supporting and bringing together the UK’s emerging life sciences companies, corporate partners, and ...
Breaking Medicine News(10 mins):